Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Spineway

Start price
Target price
Perf. (%)
€0.001
26.03.24
€3.00
-
26.02.24

Leading role in innovation
Strong uniques
Differentiated customer and product portfolio
Future proof or reliable business model
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.80
10.02.24
€5.00
10.02.25
-46.90%
02.05.24

Could be worthwhile Investment >10% per year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.89
30.12.23
€5.50
30.12.24
-22.39%
10.02.24

Could be worthwhile Investment >10% per year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.25
02.11.23
€0.50
02.11.24
-32.45%
02.05.24

Could be worthwhile Investment >10% per year
buy
Spineway

Start price
Target price
Perf. (%)
€0.61
27.05.23
-
27.05.24
-99.87%
26.02.24

buy
Spineway

Start price
Target price
Perf. (%)
€1.01
14.12.22
-
14.12.23
2.97%
24.12.22

Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition
Spineway

Start price
Target price
Perf. (%)
€2.20
10.12.22
€1.00
10.12.23
-52.73%
24.12.22

buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.04
12.11.22
€4.50
12.11.23
5.82%
13.11.23

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.71
16.08.22
€5.00
16.08.23
-14.13%
12.11.22

Could be worthwhile Investment >10% per year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
Crossject S.A.

Start price
Target price
Perf. (%)
€2.82
18.11.21
€2.50
18.11.22
66.84%
16.08.22

Could be worthwhile Investment >10% per year
buy
Mauna Kea Tech

Start price
Target price
Perf. (%)
€0.84
07.11.21
€1.10
07.11.22
-33.61%
08.11.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€15.66
20.10.21
€17.00
20.10.22
-21.52%
21.10.22

Could be worthwhile Investment >10% per year
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.15
18.10.21
€2.00
18.10.22
-89.39%
19.10.22

buy
Spineway

Start price
Target price
Perf. (%)
€60.00
17.06.21
€400.00
17.06.22
-66.67%
05.06.22

buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Spineway

Start price
Target price
Perf. (%)
€60.00
22.05.21
€40,000
22.05.22
-66.67%
23.05.22

buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€2.07
08.03.21
€1.80
08.03.22
-72.56%
09.03.22

Pixium Vision S.A.

Start price
Target price
Perf. (%)
€2.07
06.03.21
€0.000
-11.21%
20.03.21

buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year